The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7902331PMCID PMC1422124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules

  1992cited by this paper
• Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites.

  1992cited by this paper
• Plasmodium yoelii: quantification of the exoerythrocytic stages based on the use of ribosomal RNA probes.

  1991cited by this paper
• CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

  1991cited by this paper
• The multifactorial character of the protective immunity induced by immunization with sporozoites.

  1991cited by this paper
• Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

  1991cited by this paper
• Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.

  1991cited by this paper
• In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.

  1991cited by this paper
• Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

  1991cited by this paper
• Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells.

  1990cited by this paper
• Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

  1990cited by this paper
• CD4+ cytolytic T cell clone confers protection against murine malaria

  1990cited by this paper
• The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

  1990cited by this paper
• Peptide-primed CD4+ cells and malaria sporozoites.

  1990cited by this paper
• In vivo inhibition of the antibody response by a complement receptor- specific monoclonal antibody

  1990cited by this paper
• Genetic control of immunity to Plasmodium yoelii sporozoites.

  1989cited by this paper
• Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

  1989cited by this paper
• Rationale for the development of an engineered sporozoite malaria vaccine.

  1989cited by this paper
• CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

  1987cited by this paper
• Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

  1987cited by this paper
• Synthetic peptide vaccine confers protection against murine malaria

  1987cited by this paper
• Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

  1980cited by this paper
• Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.

  1979cited by this paper

• Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil

  2025cites this paper
• Sporozoite immunization: innovative translational science to support the fight against malaria

  2023cites this paper
• Heterogeneity in killing efficacy of individual effector CD8+ T cells against Plasmodium liver stages

  2023cites this paper
• Immunoprofiling Identifies Functional B and T Cell Subsets Induced by an Attenuated Whole Parasite Malaria Vaccine as Correlates of Sterile Immunity

  2022cites this paper
• Harnessing liver-resident memory T cells for protection against malaria

  2021cites this paper
• Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of Plasmodium Sporozoites Indicates Diversion of Cellular Immunity

  2021cites this paper
• Identification, Selection and Immune Assessment of Liver Stage CD8 T Cell Epitopes From Plasmodium falciparum

  2021cites this paper
• Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy

  2020cites this paper
• Glycolipid-peptide vaccination induces liver-resident memory CD8+ T cells that protect against rodent malaria

  2020cites this paper
• A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model

  2020cites this paper
• Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine

  2019cites this paper
• Malaria prevention: from immunological concepts to effective vaccines and protective antibodies

  2018cites this paper
• Clustering of Activated CD8 T Cells Around Malaria-Infected Hepatocytes Is Rapid and Is Driven by Antigen-Specific Cells

  2018cites this paper
• Professor Ruth Sonntag Nussenzweig (1928-2018) First steps towards a successful anti-sporozoite vaccine against malaria.

  2018cites this paper
• Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine

  2017cites this paper
• The role of antibodies to Plasmodium falciparum merozoite antigens in the resistance of young infants to febrile malaria and their place as a biomarker in the detection of malaria transmission hotspots

  2017cites this paper
• Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice

  2017cites this paper
• Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro

  2017cites this paper
• Pre-Erythrocytic Vaccine Candidates in Malaria

  2016cites this paper
• Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection.

  2016cites this paper
• An in vitro assay to measure antibody-mediated inhibition ofmalaria sporozoite infection.

  2016cites this paper
• Subverting Immunity from the Inside: Strategies of Intracellular Survival – Protozoans

  2016cites this paper
• Antigen-driven focal inflammatory death of malaria liver stages

  2015cites this paper
• Novel approaches to whole sporozoite vaccination against malaria

  2015cites this paper
• Immunoregulation in human malaria: the challenge of understanding asymptomatic infection

  2015cites this paper
• Immune Escape Mechanisms are Plasmodium's Secret Weapons Foiling the Success of Potent and Persistently Efficacious Malaria Vaccines.

  2015cites this paper
• How country of origin, consumer ethnocentrism and consumer xenocentrism impact upon risk and involvement in the malaria medication decision making process in Tanzania

  2015cites this paper
• An Unstable Th Epitope of P. falciparum Fosters Central Memory T Cells and Anti-CS Antibody Responses

  2014cites this paper
• A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate

  2014cites this paper
• IFNγ/IL-10 Co-producing Cells Dominate the CD4 Response to Malaria in Highly Exposed Children

  2014cites this paper
• Immunization of Mice with Live-Attenuated Late Liver Stage-Arresting Plasmodium yoelii Parasites Generates Protective Antibody Responses to Preerythrocytic Stages of Malaria

  2014cites this paper
• Experimental models in vaccine research: malaria and leishmaniasis

  2013cites this paper
• Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling

  2013cites this paper
• CD8+ T Cells Specific for a Malaria Cytoplasmic Antigen Form Clusters around Infected Hepatocytes and Are Protective at the Liver Stage of Infection

  2013cites this paper
• Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines.

  2013cites this paper
• Model for In Vivo Assessment of Humoral Protection against Malaria Sporozoite Challenge by Passive Transfer of Monoclonal Antibodies and Immune Serum

  2013cites this paper
• A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria

  2012cites this paper
• CD8+ T-cell-mediated immunity against malaria: a novel heterologous prime–boost strategy

  2012cites this paper
• Identification and characterisation of new potential antigens involved in GAP-mediated immunity

  2012cites this paper
• Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity

  2011cites this paper
• Title Interferon-gamma , a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity

  2011cites this paper
• Immune Intervention in Malaria

  2011cites this paper
• Why Functional Pre-Erythrocytic and Bloodstage Malaria Vaccines Fail: A Meta-Analysis of Fully Protective Immunizations and Novel Immunological Model

  2010cites this paper
• A retrospective evaluation of the role of T cells in the development of malaria vaccine.

  2010cites this paper
• Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites

  2009cites this paper
• Antigens for pre‐erythrocytic malaria vaccines: building on success

  2009cites this paper
• Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.

  2008cites this paper
• Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii

  2008cites this paper
• Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.

  2008cites this paper
• Protective CD8+ T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’ immune response

  2008cites this paper
• CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes

  2007cites this paper
• Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.

  2007cites this paper
• IL‐12p40‐independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations

  2007cites this paper
• Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites.

  2007cites this paper
• Class II-Restricted Protective Immunity Induced by Malaria Sporozoites

  2007cites this paper
• Cellular immune responses to the cysteine-rich interdomain region-1-alpha (CIDR-1α) of Plasmodium falciparum erythrocyte membrane protein 1 (PFEMP-1).

  2005cites this paper
• Effector and memory CD8+ T cells as seen in immunity to malaria

  2004cites this paper
• T cells as mediators of protective immunity against liver stages of Plasmodium.

  2003cites this paper
• The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites.

  2003cites this paper
• Short-term antigen presentation and single clonal burst limit the magnitude of the CD8+ T cell responses to malaria liver stages

  2002cites this paper
• Mouse models for pre-erythrocytic-stage malaria.

  2002cites this paper
• Plasmodium berghei and 265 Plasmodium yoelii Against Murine Malaria The Role of IL-18 in Blood-Stage Immunity

  2002influential citation
• The Role of IL-18 in Blood-Stage Immunity Against Murine Malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA1

  2002influential citation
• Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

  2001cites this paper
• Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy.

  2001cites this paper
• Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites.

  2001cites this paper
• CD1d‐restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice

  2001cites this paper
• HLA‐A*0201 restricted CD8+ T‐lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN‐γ ELISPOT

  2000cites this paper
• Generation and characterization of malaria‐specific human CD8+ lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells

  2000cites this paper
• Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.

  2000cites this paper
• Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus

  2000cites this paper
• γδ T Cells Are a Component of Early Immunity against Preerythrocytic Malaria Parasites

  2000cites this paper
• Interferon‐γ‐independent CD8+ T cell‐mediated protective anti‐malaria immunity elicited by recombinant adenovirus

  2000cites this paper
• Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.

  1999cites this paper
• Efficient induction of protective anti-malaria immunity by recombinant adenovirus.

  1998cites this paper
• Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.

  1997cites this paper
• Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres.

  1997cites this paper
• Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein

  1997cites this paper
• Elimination of P. berghei liver stages is independent of Fas (CD95/Apo‐I) or perforin‐mediated cytotoxicity

  1997cites this paper
• Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.

  1996cites this paper
• Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.

  1995cites this paper
• A statistician looks at met-analysis.

  1995cites this paper
• Development of antimalaria immunity in mice lacking IFN-gamma receptor.

  1995cites this paper
• CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria.

  1995cites this paper